Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2004; 43:1027-1033, doi:10.1016/j.jacc.2003.10.044
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sundell, J.
Right arrow Articles by Knuuti, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sundell, J.
Right arrow Articles by Knuuti, J.

The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure

Jan Sundell, MD*{dagger}, Erik Engblom, MD{dagger}, Juhani Koistinen, MD{dagger}, Antti Ylitalo, MD{ddagger}, Alexandru Naum, MD*, Kira Q. Stolen, PhD*, Riikka Kalliokoski, MSc*, Stephan G. Nekolla, MD§, K. E. Juhani Airaksinen, MD{dagger}, Jeroen J. Bax, MD|| and Juhani Knuuti, MD*,*

* Turku PET Centre, Turku, Finland
{dagger} Departments of Medicine, University of Turku, Turku, Finland
{ddagger} Department of Medicine, Satakunta Central Hospital, Pori, Finland
§ Klinik und Poliklinik fuer Nuklearmedizin, Klinikum rechts der Isar der Technischen Universitaet Muenchen, Muenchen, Germany
|| Department of Cardiology, Leiden University, Leiden, Netherlands



View larger version (13K):

[in a new window]
 
Figure 1 Study design: patients were studied on two separate occasions: while cardiac resynchronization therapy (CRT) was switched on and after CRT was switched off for 24 h. Serum natriuretic peptides were measured immediately preceding the positron emission tomography (PET) studies. Myocardial blood flow was quantitated using PET and [15O]water ([15O]H2O) at baseline and during adenosine infusion (140 µg/kg/min for 7.5 min). Left ventricular oxidative metabolism was measured using PET and [11C]acetate at baseline and during low-dose dobutamine infusion (5 µg/kg/min for 60 min). Left ventricular function was measured using two-dimensional echocardiography first at rest and then during dobutamine infusion. Open bars = perfusion measurement; solid bars = oxidative metabolism measurement.

 


View larger version (22K):

[in a new window]
 
Figure 2 Cardiac resynchronization therapy (CRT) enhanced left ventricular stroke volume significantly at baseline but not during dobutamine-induced stress. Open bars = CRT on; solid bars = CRT off.

 


View larger version (19K):

[in a new window]
 
Figure 3 Cardiac resynchronization therapy (CRT) had no significant effect on basal- or adenosine-stimulated myocardial blood flow.

 


View larger version (23K):

[in a new window]
 
Figure 4 Left ventricular (LV) oxidative metabolism (Kmono) was unchanged by cardiac resynchronization therapy (CRT), but dobutamine-induced stress significantly increased Kmono values. Open bars = CRT on; solid bars = CRT off.

 


View larger version (21K):

[in a new window]
 
Figure 5 Cardiac resynchronization therapy (CRT) significantly increased basal myocardial efficiency, and the same, but weaker, trend was seen during dobutamine-induced stress. Open bars = CRT on; solid bars = CRT off.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement